Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „coadministration“
Suchtreffer
Begriffe & Kennungen
Alunbrig · 4.5 · 10 CYP3A. Therefore, coadministration of Alunbrig with CYP3A substrates with a narrow therapeutic index (e.g.,
Eintrag öffnenAlunbrig · 4.5 · Coadministration of brigatinib with substrates of P-gp (e.g., digoxin, dabigatran, colchicine, pravastatin), B
Eintrag öffnenAlunbrig · 4.5 · In healthy subjects, coadministration of multiple 600 mg daily doses of rifampicin, a strong CYP3A inducer, wi
Eintrag öffnenAlunbrig · 4.5 · In vitro studies demonstrated that brigatinib is a substrate of CYP2C8. In healthy subjects, coadministration
Eintrag öffnenApixaban Accord · 4.5 · 43 Inducers of CYP3A4 and P-gp Coadministration of apixaban with rifampicin, a strong inducer of both CYP3A4 a
Eintrag öffnenApixaban Accord · 4.5 · Atenolol Coadministration of a single dose of apixaban (10 mg) and atenolol (100 mg), a common beta-blocker, d
Eintrag öffnenApixaban Accord · 4.5 · Atenolol Coadministration of a single dose of apixaban (10 mg) and atenolol (100 mg), a common beta-blocker, d
Eintrag öffnenApixaban Accord · 4.5 · Digoxin Coadministration of apixaban (20 mg once a day) and digoxin (0.25 mg once a day), a P-gp substrate, di
Eintrag öffnenApixaban Accord · 4.5 · Digoxin Coadministration of apixaban (20 mg once a day) and digoxin (0.25 mg once a day), a P-gp substrate, di
Eintrag öffnenApixaban Accord · 4.5 · Inducers of CYP3A4 and P-gp Coadministration of apixaban with rifampicin, a strong inducer of both CYP3A4 and
Eintrag öffnenApixaban Accord · 4.5 · Inhibitors of CYP3A4 and P-gp Coadministration of apixaban with ketoconazole (400 mg once a day), a strong inh
Eintrag öffnenApixaban Accord · 4.5 · Inhibitors of CYP3A4 and P-gp Coadministration of apixaban with ketoconazole (400 mg once a day), a strong inh
Eintrag öffnenApixaban Accord · 4.5 · Naproxen Coadministration of single doses of apixaban (10 mg) and naproxen (500 mg), a commonly used NSAID, di
Eintrag öffnenApixaban Accord · 4.5 · Naproxen Coadministration of single doses of apixaban (10 mg) and naproxen (500 mg), a commonly used NSAID, di
Eintrag öffnenAprovel · 4.5 · 44 have not been evaluated. The pharmacokinetic of digoxin was not altered by coadministration of irbesartan.
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.5 · Interactions between atazanavir and other medicinal products, including those for which coadministration is co
Eintrag öffnenBaraclude · 4.5 · Since entecavir is predominantly eliminated by the kidney (see section 5.2), coadministration with medicinal p
Eintrag öffnenBaraclude · 4.5 · Since entecavir is predominantly eliminated by the kidney (see section 5.2), coadministration with medicinal p
Eintrag öffnenBesponsa · 4.5 · Based on in vitro data, coadministration of inotuzumab ozogamicin with inhibitors or inducers of cytochrome P4
Eintrag öffnenBraftovi · 4.5 · Transporter substrates In vivo, encorafenib is an inhibitor of OATP1B1, OATP1B3 and/or BCRP. Coadministration
Eintrag öffnen